Roman Gulati

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa — South Africa

Medicine · Health Sciences

44h-index8.4kcitations292works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(161), Prostate Cancer Diagnosis and Treatment(89), Global Cancer Incidence and Screening(67), Cancer Genomics and Diagnostics(42), Colorectal Cancer Screening and Detection(30)

Publications292 total

Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.
PubMed·2025
Supplementary Data from A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing
2025Open Access
Data from A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing
2025Open Access
Age-specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstruction
JNCI Cancer Spectrum·2025Open Access
Prostate‐specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long‐term survival
Cancer·2025
Clinical Significance of a Multicancer Screening Trial With Stage-Based End Points
JAMA Network Open·2025· 1 citedOpen Access
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer
2025Open Access
Supplementary Table 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Figure 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Table 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Figure 3 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Supplementary Table 2 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Figure S2 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Figure S1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Figure 2 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Data from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
2025Open Access
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
Cancer Research Communications·2025· 3 citedOpen Access
Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study
International Journal of Cancer·2025Open Access
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer
Journal of Clinical Investigation·2025· 8 citedOpen Access
Data from Sensitivity Measures in Studies of Cancer Early Detection Biomarkers
2025Open Access
page 1 of 15Next →

Frequent Co-authors

Ruth Etzioni(29), Peter S. Nelson(16), Colm Morrissey(11), Alex Tsodikov(10), Angela B. Mariotto(10), Bruce Montgomery(9), Ilsa M. Coleman(9), Eveline A.M. Heijnsdijk(8), Lawrence D. True(7), Harry J. de Koning(7), Robert L. Vessella(6), Eric J. Feuer(6), Eva Corey(6), John L. Gore(6), Heather H. Cheng(5), Lisha G. Brown(5), Evan Y. Yu(5), David F. Penson(5), Paul H. Lange(4), Martine P. Roudier(4)